References
1. Lee JM. Dongeisusebowon 2nd revth ed. Seoul: Yeogang; 2003. 36p. 278. (Korean).
2. Hwang MW. The lecture of Sasang constitution 2nd Editionth ed. Seoul: Koonja; 2012. p. 33–40.
(Korean).
3. Dept of Sasang Constitutional Medicine. All colleges of Korean med in Korea(compilation). The revised and enlarged Sasang Constitutional Medicine Seoul: Jipmoondang; 2012. p. 136–144.
(Korean).
4. Hwang MW, Koh BH. The Study on the Pathology of Soyangin in Sasang Constitutional Medicine(SCM). Journal of Sasang Constitutional Medicine 2009;21(3):1–16.
5. Lalich JJ, Burkholder PM, Paik WC. Protein overload nephropathy in rats with unilateral nephrectomy. A correlative light immunogluorescence and electron microscopical analysis. Archives of pathology 99(2)1975;:72–79.
6. Park SB. The Relation of Cardiovascular Risk Factors to Metabolic Syndrome. Journal of the Korean Academy of Family Med 2005;26(10):20–26.
7. Sim JY, Kang HT, Kim SY, Kim JS, Kim JW, Kim JY, et al. The Prevention and Treatment of Metabolic Syndrome in Korean Adults. Korean Journal of Family Practice 2015;5(3):375–420.
8. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012;33:1635–701.
9. Lee TG, Hwang MW, Lee SK, Choe BK, Koh BH, Song IB. A Study on the Prevalence and Risk Factors of the Metabolic Syndrome according to Sasang Constitution. Journal of Korean Med 2006;27(2):14–22.
10. Kim DR. A Study on 4 Type Constitution and Life Character of Obese Patients. Journal of Sasang Constitutional Medicine 1997;9(1):303–313.
11. Yang SM. Association between Risk Factors and Prevalence of Metabolic Syndrome according to Sasang Constitution in Wonju Cohort Study. Doc of Sangji Univ 2007;
12. Choi JW, Yu JS. Cut-off Values of Waist Circumference and Body Mass Index for Metabolic Syndrome according to Sasang Constitution. Journal of Sasang Constitutional Medicine 2014;26(4):365–378.
13. Choi KJ. A Study on the Influence of Sasang Constitution on Insulin Resistance. Doc of Kyunghee Univ 2010;
14. Lee JW, Jang HS, Park BJ, Lee EJ, Koh BH, Lee JH. Can the Sasang Constitutional Type Trait Act as an Independent Risk Factor for Dyslipidemia? Journal of Korean Med. Obesity Research 2014;14(2):63–71.
15. Kim YH, Park JH, Kwak JY, Park JM, Ahn TW. A Study of the Effect on Obesity in Taeeumin Animal-experimental Model Induced Lung Fibrosis with Bleomycin. Journal of Sasang Constitutional Medicine 2016;28(2):147–162.
16. Park JH, Kim YH, Kwak JY, Hong SJ, Park JM, Ahn TW. A study on the effect on obesity and lipid metabolism in liver hypofunction animal-experimental model induced by Acetaminophen(AAP) injection. Journal of Korean Med 2016;37(3):47–61.
17. Kim KB, Park SO. 2001;A study of the correlation of stress and powerlessness based on hemodialysis patients’ constitution of the Korea. Journal of East-West Nursing Research 6(1):7–22.
18. Kim JD. 上壽如水: My Sassang constitution and characteristic 4. pastoral information 3(4)2010;:102–104.
19. Kim BH, Joe DY, Lee SH, Park SE, Ga MK. Generation Sasang Constitution Diagnosis and Classification Using Acoustics Analysis Element. Korea information and communications society 2006;:614–617.
20. Park GS, Han JS, Kim HJ. Effect of Diet Contents on Serum Composition and Urinary Excretion in Female Students according to Sasang Constitution. J East Asian Soc Dietary Life 1998;8(3):271–279.
21. Moon SH, Sin SH, Kim HJ, Kim JY. A Relationship of the Obesity and Body Composition Analysis by Sasang Constitution. Journal of Korean Rehabilitation Med 2002;12(4):1–10.
22. Ucero AC, Benito-Martin A, Izquierdo MC, Sanchez-Niño MD, Sanz AB, Ramos AM, et al. Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol 2014;46(4):765–776.
23. Hwang GH, Noh YH, Heo YR. A Study on Hyperlipidemia in Koreans - Specially Related to Hematological Characteristics and Risk Factors of Hypercholesterolemia. Journal of the Korean Society of Food Science and Nutrition 1999;28(3):710–721.
24. Lee HJ, Shin GJ, Park SH, Cho HK. Insulin Resistance and Visceral Fat Obesity in Hyperlipidemia. Korean Circulation Journal 1999;29(7):673–679.
25. Byrne CD, Brindel NPJ, Wang TWM, Hales CN. Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. J Biochem 1991;280:99–104.
26. Randle PF, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle in obesity and maturity onset diabetes mellitus. Ann NY Acad Sci 1965;131:324–33.
27. Yoon HJ, Lee YH, Cha BS. Causal Relationship of Non-alcoholic Fatty Liver Disease with Obesity and Insulin Resistance. Journal of Korean Diabetes 2014;15:76–81.
28. DeBosch BJ, Kluth O, Fujiwara H, Schürmann A, Moley K. Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. Nat Commun 2014;5:4642.
29. Shin YT, Kim KK, Hwang IC. Clinical Implication of Plasma Uric Acid Level. Korean Journal of Family Medicine 2009;30(9):670–680.
30. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995;268:1–5.
31. Eder K, Baffy N, Falus A, Fulop AK. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009;58(11):727–736.
32. Sindhu S, Thomas R, Shihab P, Sriraman D, Behbehani K, Ahmad R. Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PLos One 2015;10(7):e0133494.
33. Stouthard JM, Romijn JA, Van der Poll T, et al. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995;268:813–319.